Y. Kwan

发表

Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non‐Hodgkin's lymphoma

R. Mansberg, A. Dorigo, Y. Kwan, 1993, European journal of haematology.

Formalising multidisciplinary peer review: developing a haematological malignancy‐specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence‐based clinical practice

J. Fletcher, J. Trotman, J. Estell, 2017, Internal medicine journal.

Platelet activation in the hypertensive disorders of pregnancy

M. Brown, A. Trickett, T. Brighton, 2002, American journal of obstetrics and gynecology.

Flexible Low-Intensity Combination Chemotherapy for Elderly Patients with Acute Myeloid Leukemia

A. Trickett, T. Brighton, A. Manoharan, 2002, International journal of hematology.

T cell stimulation and expansion using anti-CD3/CD28 beads.

A. Trickett, Y. Kwan, 2003, Journal of immunological methods.

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.

I. Kerridge, C. Tiley, A. McLachlan, 2016, British journal of clinical pharmacology.

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.

J. Burke, K. Kolibaba, I. Flinn, 2014, Blood.

Pulmonary embolism in patients with intermediate probability lung scans: diagnosis with Doppler venous US and D-dimer measurement.

P. Travers, S. P. Butler, D. W. Glenn, 1994, Radiology.

The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation

S. Ramanathan, A. Trickett, Y. Kwan, 2012, Annals of Hematology.

Christopher, C. Tam, A. Schwarer, 2014 .

Myelodysplastic syndromes: prognostic significance of multilineage dysplasia in patients with refractory anemia or refractory anemia with ringed sideroblasts.

S. Dunkley, A. Manoharan, Y. Kwan, 2002, Blood.

Sideroblastic anaemia and leukaemia in multiple myeloma.

Y. Kwan, K. Phadke, S. Young, 1978, Australian and New Zealand journal of medicine.

Heparin‐induced thrombocytopenia: cross‐reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran)

R. Ramakrishna, A. Manoharan, Y. Kwan, 1995, British journal of haematology.

Ex vivo expansion of functional T lymphocytes from HIV-infected individuals.

J. Dwyer, A. Trickett, B. Cameron, 2002, Journal of immunological methods.

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

A. Manoharan, Y. Kwan, R. Wong, 2007, Annals of Hematology.

Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease.

R. Leong, J. Trotman, N. Moran, 2015, World journal of gastroenterology.

Bone‐marrow transplantation for haematological malignancy in childhood

J. Ziegler, H. Mameghan, D. O'Gorman-Hughes, 1986, The Medical journal of Australia.

Dientamoeba fragilis: a family cluster of disease associated with marked peripheral eosinophilia.

T. Gottlieb, T. Gray, Y. Kwan, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR

L. To, A. Trickett, D. Ma, 2003, Leukemia.

Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma1

Frederick Luk, M. Bebawy, Ross D. Brown, 2016, Neoplasia.

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.

C. Tam, A. Schwarer, D. White, 2015, Blood.

A sensitive method for the detection of poly‐A tails of mRNA using a biotin‐labelled heteropolymer OF dT:rA

B. Markovic, Y. Kwan, R. Crouch, 1992, The Journal of pathology.

An improved method of alkaline phosphatase — antialkaline phosphatase immunophenotyping using microwave irradiation

Y. Kwan, Anastasia Flokis, F. Ip, 1991, Pathology.

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.

I. Kerridge, Peter Shaw, C. Tiley, 2010, British journal of clinical pharmacology.

The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L.

A. Trickett, J. Case, Y. Kwan, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

CLINICAL AND LABORATORY STUDIES OF 1,25‐DIHYDROXYCHOLECALCIFEROL IN MYELOFIBROSIS

R. Mason, A. Manoharan, Y. Kwan, 1987, British journal of haematology.

Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II Trial

A. Schwarer, D. White, T. Hughes, 2010 .

Upfront Imatinib Therapy in CML Patients with Rapid Switching to Nilotinib for Failure to Achieve Molecular Targets or Intolerance Achieves High Overall Rates of Molecular Response and a Low Risk of Progression - An Update of the TIDEL-II Trial

A. Schwarer, D. White, T. Hughes, 2011 .

Early Switch to Nilotinib Does Not Overcome the Adverse Outcome for CML Patients Failing to Achieve Early Molecular Response On Imatinib, Despite Excellent Overall Outcomes in the TIDEL II Trial

A. Schwarer, D. White, T. Hughes, 2012 .

Incidence and clinical significance of protein‐bound vitamin B12 malabsorption

C. S. Grace, Y. Kwan, A. Broomhead, 1987, European journal of haematology.

PHILADELPHIA CHROMOSOME POSITIVE BURKITT TYPE ACUTE LYMPHOBLASTIC LEUKAEMIA

M. Yip, Y. Kwan, R. McKinley, 1986, British journal of haematology.

ACUTE LEUKEMIA CHARACTERIZED BY TRISOMY 8 IN DOWN'S SYNDROME

Y. Kwan, A. Broomhead, P. Lam-po-tang, 1985, Pathology.

Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantation.

A. Trickett, S. Smith, Y. Kwan, 2001, Cytotherapy.

Retrospective pharmaceutical financial benefits and cost avoidance analysis of clinical trial participation in the Australian haematology setting

J. Trotman, Y. Kwan, A. Huseincehajic, 2019, Internal medicine journal.

Trisomy 4 in a case of acute biphenotypic leukemia.

M. Yip, L. White, Y. Kwan, 1990, Cancer genetics and cytogenetics.